What Fueled The Previous Growth In The Neuroscience Antibodies & Assays Market?
The neuroscience antibodies & assays market has seen considerable growth due to a variety of factors.
• In recent years, there has been fast-paced growth in the size of the neuroscience antibodies & assays market. The market, which stood at $4.52 billion in 2024, is predicted to reach $5.07 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.2%.
The notable growth during the historical period can be ascribed to factors such as research funding, advancements in drug discovery and development, the prevalence of neurodegenerative diseases, government initiatives, and the rise in personalized medicine.
What Is The Expected Growth In The Neuroscience Antibodies & Assays Market Size?
The neuroscience antibodies & assays market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of neuroscience antibodies and assays is predicted to encounter a swift expansion in the coming years. It is estimated to escalate to a value of $8.74 billion in 2029, projecting a compound annual growth rate (CAGR) of 14.6%.
The expected growth during the forecast period is credited to factors such as collaborations, the prominence of telemedicine in neurology, education and training, therapies driven by biomarkers, and concentrated focus on neuroimmunology. Key trends projected during the forecast period include assays of microrna and non-coding RNA, digital pathology, advanced imaging-compatible assays, analysis at the single-cell level, and 3D organoid models.
What Are The Leading Drivers Of Growth In The Neuroscience Antibodies & Assays Market?
The rise in cases of neurological diseases worldwide is anticipated to boost the growth of the neuroscience antibodies & assays market. Neurological diseases are conditions that impact the nervous system, with examples including Alzheimer’s disease, dementia, epilepsy, and more. The growing prevalence of these neurological diseases necessitates more research and development for their treatment. Antibodies and assays play a crucial role in these R&D efforts by helping to understand the development, structure, systems, and functions of the nervous system, along with its disorders and degeneration. Hence, the growth of the neuroscience antibodies & assays market is directly linked to the increasing incidences of neurological diseases. As an illustration, the Centers for Disease Control and Prevention, a federal agency based in the US, revealed in May 2024 that nearly 2.9 million U.S. adults aged 18 and above reported active epilepsy during 2021 and 2022. Meanwhile, the Alzheimer's Association, a US-based Non-profit association, states that Alzheimer's disease affected 6.5 million people in the US according to the data from 2022. Consequently, the surge in neurological diseases worldwide is spurring the advancement of the neuroscience antibodies and assays market.
How Are The Segments Defined Within The Global Neuroscience Antibodies & Assays Market?
The neuroscience antibodies & assays market covered in this report is segmented –
1) By Product: Consumables, Instruments
2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies
3) By Application: In Vitro Diagnostics, Research, Drug Discovery
4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Consumables: Antibodies, Assay Kits, Assay Kits
2) By Instruments: Spectrophotometers, Microplate Readers, Flow Cytometers, Western Blotting Systems, Imaging Systems, Automated Workstations
Pre-Book The Neuroscience Antibodies & Assays Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Neuroscience Antibodies & Assays Market?
The rise in technological advancements is a significant trend making waves in the neuroscience antibodies and assays market. To maintain their market standing, key corporations are unveiling state-of-the-art technologies such as the NeuroNexus Summa Framework technology. For example, NeuroNexus Technologies, an American company offering innovative neural interface products and technologies, declared the rollout of the NeuroNexus Summa Framework in February 2022. This solution was crafted with both seasoned electrophysiologists and life science researchers in mind, making it easier to integrate electric signal read-outs from biological cells and tissues in their research processes.
Who Are the Key Players in the Neuroscience Antibodies & Assays Market?
Major companies operating in the neuroscience antibodies & assays market include:
• Abcam plc
• BioLegend Inc.
• Bio-Rad Laboratories Inc.
• Cell Signaling Technology Inc.
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific
• Merck KGaA
• Rockland Immunochemicals Inc.
• GenScript Biotech Corporation
• Santa Cruz Biotechnology Inc.
• Wak-Chemie Medical GmbH
• Epitope Diagnostics Inc.
• Agilent Technologies
• Bio-Techne Corporation
• Creative Diagnostics
• Enzo Life Sciences Inc.
• Jackson ImmunoResearch Laboratories Inc.
• Novus Biologicals LLC
• OriGene Technologies Inc.
• Proteintech Group Inc.
• R&D Systems Inc.
• RayBiotech Inc.
• StressMarq Biosciences Inc.
• Synaptic Systems GmbH
• Tocris Bioscience
• Alomone Labs Ltd.
• AnaSpec Inc.
• Antibodies.com
• Antibody Solutions
• Arbor Assays
• Uscn Life Science Inc.
• Zymo Research Corp.
• AAT Bioquest Inc.
• Abbexa Ltd.
• ACROBiosystems Inc.
• Active Motif Inc.
• AdipoGen Life Sciences
• Advanced Targeting Systems Inc.
• AgriSera AB
What Is The Most Dominant Region In The Neuroscience Antibodies & Assays Market?
North America was the largest region in the neuroscience antibodies & assays market in 2024. The regions covered in the neuroscience antibodies & assays market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
